0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.14%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-13.81%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
0.61%
EBIT growth below 50% of 0259.HK's 68.94%. Michael Burry would suspect deeper competitive or cost structure issues.
0.61%
Positive operating income growth while 0259.HK is negative. John Neff might view this as a competitive edge in operations.
27.53%
Positive net income growth while 0259.HK is negative. John Neff might see a big relative performance advantage.
-44.39%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
3.34%
Positive diluted EPS growth while 0259.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
129.62%
Share count expansion well above 0259.HK's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
23.43%
Diluted share change of 23.43% while 0259.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
114.48%
OCF growth under 50% of 0259.HK's 8187.67%. Michael Burry might suspect questionable revenue recognition or rising costs.
79.98%
FCF growth under 50% of 0259.HK's 1098.96%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
31.83%
Positive 10Y revenue/share CAGR while 0259.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-55.08%
Negative 5Y CAGR while 0259.HK stands at 9.52%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-50.53%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
305.97%
Positive long-term OCF/share growth while 0259.HK is negative. John Neff would see a structural advantage in sustained cash generation.
-9.31%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-66.91%
Negative 3Y OCF/share CAGR while 0259.HK stands at 46.12%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-34.65%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-33.96%
Negative 5Y net income/share CAGR while 0259.HK is 6.96%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
110.85%
Positive short-term CAGR while 0259.HK is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-3.30%
Negative 5Y equity/share growth while 0259.HK is at 91.37%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-32.09%
Negative 3Y equity/share growth while 0259.HK is at 52.06%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 0259.HK stands at 139.99%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-55.41%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
83.57%
Inventory growth well above 0259.HK's 2.66%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-17.48%
Negative asset growth while 0259.HK invests at 6.15%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-51.38%
We have a declining book value while 0259.HK shows 9.17%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-83.12%
We’re deleveraging while 0259.HK stands at 47.34%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-18.82%
Our R&D shrinks while 0259.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-17.25%
We cut SG&A while 0259.HK invests at 4.09%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.